arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PMGC Holdings Inc.

ELAB
$4.56 ▲ +0.28 (+6.54%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
19 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

PMGC Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $22.2M
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC None
FCF / Share $-0.41 ↗
Trailing P/E —
Price / Book 1.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

19-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.31M
↑ +91.6% —
Net Income Profit after all expenses
$-2.94M
↓ -423.0% —
Operating Margin Operating profit as % of sales
-174.4%
↑ +25.0% —
FCF / Share Free cash flow per share
$-0.41
↑ +94.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑
9
Cash Quality ↓
56

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 19 quarters